Presentation TCT 2012 Case Review 4: How to Deal with Valve Complications Presenter: Jason Rogers October 25, 2012 REGISTER for free or LOG IN to view this content Mitral Valve Presentation TCT 2012 Up Next Presentation TCT 2012 Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI! Presenter: Roxana Mehran October 25, 2012 More slides + Presentation TCT 2012 "Impact of the Presence and Extent of Incomplete Angiographic Revascularization after Percutaneous Coronary Intervention in Acute Coronary Syndromes: The ACUITY Trial."... Presenter: Gregg Rosner October 24, 2012 Presentation TCT 2012 Drip, Ship, and Fix or Drip, Ship, and Wait? Presenter: Christopher Buller October 24, 2012 We Recommend
Presentation TCT 2012 Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI! Presenter: Roxana Mehran October 25, 2012
Presentation TCT 2012 "Impact of the Presence and Extent of Incomplete Angiographic Revascularization after Percutaneous Coronary Intervention in Acute Coronary Syndromes: The ACUITY Trial."... Presenter: Gregg Rosner October 24, 2012
Presentation TCT 2012 Drip, Ship, and Fix or Drip, Ship, and Wait? Presenter: Christopher Buller October 24, 2012